Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.

Renal failure - 1 Jan 2005

Shu Kuo-Hsiung, Cheng Chi-Hung, Wu Ming-Ju, Chen Cheng-Hsu, Lee Wen-Chin

Abstract excerpt

End-stage-renal disease (ESRD) is a final result of various etiologies. Prognostic indicators leading to ESRD in chronic kidney diseases have been studied extensively, of which, genetic factors remain a subject of great concern. Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Kidney Failure, Chronic

Share to Polymorphism, Genetic

Share to Receptors, Interleukin-1

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 15717635

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15717635-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.PMID 15717635Read ↗

Interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphisms and the prediction of the risk of end-stage renal disease.Semantic proximity Read ↗

Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.Semantic proximity Read ↗

Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.Semantic proximity Read ↗

Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.Semantic proximity Read ↗

Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.Semantic proximity Read ↗

Association of IL-6, IL-10, and TNF-α gene polymorphism with malnutrition inflammation syndrome and survival among end stage renal disease patients.Semantic proximity Read ↗

Role of non-HLA genetic variants in end-stage renal disease.Semantic proximity Read ↗

Interleukin-1 gene cluster polymorphisms predict risk of ESRD.Semantic proximity Read ↗

Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy.Semantic proximity Read ↗

Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease.Semantic proximity Read ↗

Immune-Related Gene Polymorphisms and Pharmacogenetic Studies in Nephrology.Semantic proximity Read ↗

Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.